FDA-Cleared Class II Device

    NS100 Neuromodulation Therapy

    by NeuroDynamics Global

    NS100 by NeuroDynamics Global is an FDA-cleared Class II peripheral nerve stimulation device for chronic pain associated with painful diabetic neuropathy. It is used over a 20-day temporary protocol and is not a permanent implant.

    Use of NS100 requires evaluation and prescription by a qualified healthcare provider. Patients can ask their clinician whether NS100 is appropriate for them.

    Published research and study summariesInformation for healthcare providers

    For healthcare providers

    Before you inquire

    To help us address your product-information request, consider the following practice-level details.

    • Practice specialty

      Your specialty and professional role within the practice.

    • Intended workflow

      Where training, implementation, or operational support questions fit within your current practice workflow.

    • Product-information questions

      The device specifications, training requirements, or implementation topics you want to discuss.

    Please do not include patient names, records, diagnoses, or other clinical personal information in your inquiry.

    Device Specifications

    NS100 delivers electrical stimulation to peripheral nerves over a 20-day protocol; individual results vary.

    Dimensions
    Compact lead design
    Weight
    Lightweight wearable
    Power
    External pulse generator
    Stimulation
    Programmable parameters
    Waveform
    Biphasic electrical pulses
    Duration
    20-day wear period

    Peripheral Nerve Electrical Stimulation

    NeuroDynamics Global delivers targeted electrical stimulation to peripheral nerves to help modulate pain signals associated with painful diabetic neuropathy.

    20-Day Temporary Protocol

    Unlike permanent implants, the NeuroDynamics Global device is worn for a defined 20-day period and then removed in a simple office procedure.

    FDA-Cleared Class II Device

    NeuroDynamics Global has received FDA clearance as a Class II medical device for the treatment of chronic pain due to PDN.

    Minimally Invasive Design

    Designed for implantation by trained healthcare providers, with minimal disruption to practice workflow.

    20-Day Protocol Timeline

    A temporary therapy with provider evaluation and follow-up.

    Day 0

    Device Implantation

    Minimally invasive treatment performed during an office visit under topical anesthesia, with patients returning home the same day. The treatment setting must comply with applicable state requirements and the treating clinician's assessment. Patient receives training on device use.

    Days 1-5

    Therapy Initiation

    Patient wears device continuously. Stimulation parameters adjusted as needed.

    Days 6-15

    Active Treatment

    Ongoing therapy delivery. Patient continues normal daily activities.

    Days 16-19

    Therapy Completion

    Final days of stimulation protocol. Follow-up assessment scheduled.

    Day 20

    Device Removal

    Simple in-office removal procedure. Patient outcomes evaluated.

    Treatment Progress

    Day 0
    Implant
    Day 5
    Initiation
    Day 10
    Mid-point
    Day 15
    Active
    Day 20
    Removal

    Clinical Workflow

    A streamlined process designed for real-world clinical settings.

    1

    Patient Identification

    Identify PDN patients who may benefit from NeuroDynamics Global therapy

    2

    Insurance and Reimbursement

    Talk to your sales representative about the reimbursement process.

    3

    Procedure Scheduling

    Schedule implantation procedure and patient training

    4

    Device Implantation

    Perform implantation under topical anesthesia

    5

    20-Day Therapy

    Patient wears device; clinical support as needed

    6

    Device Removal

    Remove device and document patient outcomes

    Full operational support at every step

    NeuroDynamics Global provides training, clinical liaison support, and revenue cycle management assistance to help ensure smooth implementation.

    Request Program Information

    Indications for Use

    The NeuroDynamics Global device is indicated for the treatment of chronic pain associated with painful diabetic neuropathy (PDN). The device should be used under the direction of a licensed healthcare provider trained in its use.

    Important Safety Information

    The NeuroDynamics Global device is an FDA-cleared Class II medical device. As with any medical procedure, there are potential risks. Patients should discuss all risks and benefits with their healthcare provider. Full prescribing information is available upon request.

    NS100 frequently asked questions

    What is NS100?
    NS100 by NeuroDynamics Global is an FDA-cleared Class II peripheral nerve stimulation device for chronic pain associated with painful diabetic neuropathy. It is used over a 20-day temporary protocol and is not a permanent implant.
    How can a patient get NS100?
    Use of NS100 requires evaluation and prescription by a qualified healthcare provider. Patients can ask their clinician whether NS100 is appropriate for them.
    How do providers request NS100 information?
    Providers can use the provider inquiry form on our Contact page to request device, training, and implementation information.
    Who do I contact with questions?
    Contact NeuroDynamics Global at questions@neurodynamics.health or +1 (888) 385-4356, or use the form on our Contact page.

    New to the term? Read What Is a Peripheral Nerve Stimulator? A Plain-English Overview.

    Important medical disclaimer. This content is for general informational and educational purposes only and is not medical advice, diagnosis, or treatment. It does not establish a physician–patient relationship. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or therapy.

    About NS100 by NeuroDynamics Global. NS100 is an FDA-cleared Class II peripheral nerve stimulation medical device for chronic pain associated with painful diabetic neuropathy. Use of NS100 requires evaluation and prescription by a qualified healthcare provider. As with any medical device, NS100 carries potential risks; your provider will review indications, contraindications, and possible side effects with you.

    Results vary. Individual results and experiences vary from patient to patient. No specific outcome is guaranteed. Insurance coverage and reimbursement are payer- and plan-specific. Talk to your provider about insurance reimbursement for your situation.

    Ready to bring NeuroDynamics Global to your practice?

    Contact us for detailed clinical information, training requirements, and program implementation support.